GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.8513 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.8902 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, HMGCR, HSD17B2, IGF1R, MMP2, MMP3, MMP9, NR3C1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR |
11.9822 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR, XDH |
11.7049 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, HMGCR, MIF, PIM1, PPARA, PTAFR, PTGES, TYR, XDH |
11.6474 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, FABP3, FABP4, HMGCR, HSD11B1, HSD17B1, HSD17B2, MET, MIF, PPARA, PTGES, TRPV1 |
10.7848 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
9.77433 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, ESR1, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
9.77433 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APP, AR, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR |
9.24319 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APP, AR, AXL, CA2, CA3, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP3, MMP9, NR3C1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR |
8.43401 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, CSNK2A1, CYP1B1, ESR1, ESRRA, F2, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PGR, PIM1, PTAFR, PTGES, SRC, XDH |
8.00487 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, SRC |
7.66094 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, FLT3, NR3C1, PTAFR, PTGES, SRC, TRPV1, TYR |
7.5689 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MIF, MMP1, MMP2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, PTGES, SRC, TYR, XDH |
7.46211 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES |
7.45459 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, NR3C1, PPARA, PRKCD, PTAFR, SRC, TRPV1 |
7.29225 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, F2, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2, KDR, MAOA, MET, MIF, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
7.24959 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES |
7.22173 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
7.06898 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
6.85773 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, NR3C1, PTAFR, PTGES, SRC, TYR |
6.81996 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, SRC |
6.79258 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, PGR, PIM1, PPARA, SRC |
6.62621 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP3, MMP9, PIM1, PPARA, PRKCD, SRC, TRPV1, XDH |
6.62621 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP3, MMP9, PRKCD, PTGES, SRC |
6.60836 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F2, F3, FLT3, HCAR2, HMGCR, KDR, MET, MIF, MMP12, MMP9, PRKCD, SRC, XDH |
6.60836 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F2, F3, FLT3, HCAR2, HMGCR, KDR, MET, MIF, MMP12, MMP9, PRKCD, SRC, XDH |
6.58051 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, NR3C1, PPARA, PRKCD, PTAFR, SRC, TRPV1 |
6.53694 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES |
6.51877 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD11B1, HSD17B1, HSD17B2, MAOA, TYR, XDH |
6.38589 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
5.89945 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA3, CA9, CYP1A1, CYP1B1, DRD1, FABP3, HMGCR, KDR, MMP3, NR3C1, PRKCD, PTAFR, SRC, TRPV1 |
5.89755 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES |
5.89755 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, MMP3, NR3C1, PRKCD, PTAFR, SRC, TRPV1 |
5.88495 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCD, SRC, TRPV1, XDH |
5.81051 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA |
5.79956 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
5.79675 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP3, MMP9, NR3C1, PRKCD, PTAFR, SRC, TRPV1 |
5.78762 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.78553 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.78553 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGES |
5.71772 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.5436 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CA2, CA3, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, F2, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, MIF, MMP12, MMP2, MMP3, MMP9, NR3C1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR |
5.48104 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.33714 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP3, MMP9, NR3C1, PRKCD, PTAFR, SRC, TRPV1 |
5.33221 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, SRC, TRPV1, XDH |
5.23693 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRB, F2, F3, FABP4, HMGCR, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP3, MMP9, PIM1, PPARA, PRKCD, PTAFR, SRC, TRPV1, TYR |
5.21163 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FABP4, HMGCR, MET, MIF, PPARA, PTGES |
5.20096 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, NR3C1, PTAFR, SRC, TRPV1 |
5.04887 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA |
5.00353 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CSNK2A1, ESR1, F2, F3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTAFR |
4.93719 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR, XDH |
4.8651 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES |
4.84068 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F2, F3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTAFR, SRC, TRPV1 |
4.78951 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, F2, HCAR2, HMGCR, KDR, MIF, SRC, TRPV1 |
4.72111 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
4.72111 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.63979 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP3, MMP9, PRKCD, SRC |
4.63979 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APP, AR, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, PRKCD, PTAFR, SRC, TRPV1 |
4.57297 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCD, SRC |
4.55806 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, MAOA, MMP1, MMP12, MMP2, MMP3, MMP9, SRC, XDH |
4.55777 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP3, MMP9, NR3C1, PIM1, PPARA, PRKCD, PTGES, SRC, TRPV1, XDH |
4.55777 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, ESRRA, F2, F3, FABP4, FLT3, HMGCR, KDR, MET, MIF, MMP12, MMP2, MMP3, MMP9, PRKCD, PTAFR, SRC, XDH |
4.55028 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
4.48213 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP3, MMP9, NR3C1, PGR, PIM1, PPARA, PRKCD, PTGES, SRC, TRPV1, XDH |
4.4759 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
4.4494 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DRD1, HMGCR, MAOA, PTAFR, TYR |
4.42803 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTGES, SRC, TRPV1, TYR, XDH |
4.38571 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCD, SRC |
4.31767 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
4.20015 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
4.16603 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC |
4.15276 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, ESR1, F2, F3, FABP4, HMGCR, KDR, MET, MIF, MMP12, PPARA, PRKCD |
4.08714 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, MIF, PRKCD, PTAFR |
4.08714 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
4.05278 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTAFR, SRC, TRPV1 |
4.05278 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, F2, FABP3, FLT3, HCAR2, HMGCR, PPARA, PRKCD, SRC |
4.02819 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F2, F3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PRKCD, SRC, XDH |
4.02108 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DRD1, ESR1, FLT3, IGF1R, MMP2, NR3C1, PRKCD, PTAFR, SRC, TRPV1 |
3.97502 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, CYP2D6, ESR1, ESR2, ESRRA, F2, FABP4, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP3, MMP9, NR3C1, PGR, PPARA, PRKCD, SRC, TRPV1, XDH |
3.96493 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F2, F3, FLT3, HMGCR, KDR, MET, MIF, MMP12, MMP9, PRKCD, SRC, XDH |
3.95312 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, F2, KDR, SRC, TRPV1 |
3.93861 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, FABP3, FLT3, IGF1R, MMP2, MMP3, PPARA, PRKCD, PTAFR, SRC, TRPV1, TYR |
3.87789 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, CA2, CYP1B1, ESRRB, F2, F3, HCAR2, HMGCR, KDR, MET, MIF, MMP12, MMP9, PIM1, PTAFR, SRC, TRPV1 |
3.87789 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGES |
3.87538 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC |
3.87538 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, F2, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PRKCD, SRC, XDH |
3.84891 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, F2, HCAR2, MIF, MMP12, PRKCD, PTAFR, SRC, TRPV1 |
3.82317 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, DRD1, ESRRB, F2, FABP3, FLT3, HMGCR, KDR, MIF, MMP9, PRKCD, PTAFR, SRC, XDH |
3.82317 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, DRD1, ESRRB, F2, FABP3, FLT3, HMGCR, KDR, MIF, MMP9, PRKCD, PTAFR, SRC, XDH |
3.82317 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CYP1B1, F2, F3, FLT3, HMGCR, KDR, MET, MIF, SRC, XDH |
3.76301 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, F2, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, PRKCD, SRC, XDH |
3.75839 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP3, MMP9, NR3C1, PRKCD, PTAFR, SRC, TRPV1 |
3.734 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, HMGCR, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, SRC |
3.71111 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CA3, CYP1A1, CYP1B1, DRD1, HMGCR, KDR, PRKCD, SRC |
3.69598 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.64439 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, CSNK2A1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, PTAFR, SRC, XDH |
3.63859 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, HMGCR, HSD11B1, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PGR, PIM1, PPARA, PRKCD, SRC, TYR |
3.63234 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, ESR1, F2, F3, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP2, MMP3, PPARA, PRKCD, SRC, XDH |
3.56771 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PRKCD, SRC |
3.53459 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, FABP3, FLT3, IGF1R, MMP2, PPARA, PRKCD, PTAFR, SRC, TRPV1, TYR |
3.53359 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP3, MMP9, TRPV1 |
3.53359 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC |
3.53037 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, MAOA |
3.52921 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MIF, MMP9, PTAFR, SRC |
3.51966 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, MMP3, PRKCD, PTAFR, SRC, TRPV1 |
3.48751 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.46412 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, MET, MIF, PIM1, PRKCD, SRC, TYR |
3.45475 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP3, MMP9, PRKCD, SRC |
3.44266 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1 |
3.39649 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CA3, CYP1B1, MMP3, MMP9, PRKCD, SRC |
3.38915 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, PTAFR, SRC |
3.38915 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD11B1, HSD17B1, HSD17B2, MIF, PTGES |
3.36924 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP3, MMP9 |
3.35038 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, ESRRA, ESRRB, F2, FLT3, HSD11B1, HSD17B2, KDR, MMP9, PGR, PIM1, PPARA, SRC, TYR |
3.28066 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.28019 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.23715 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, PPARA, PRKCD, SRC |
3.21763 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, DRD1, ESRRB, F2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PRKCD, PTAFR, SRC, XDH |
3.20249 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, PTAFR |
3.18821 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.18821 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HMGCR |
3.18821 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP3, MMP9, PRKCD, SRC |
3.17911 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
3.17366 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, CA2, CYP1B1, ESR1, ESRRA, ESRRB, F2, F3, HCAR2, HMGCR, KDR, MET, MIF, MMP12, MMP9, PIM1, PRKCD, PTAFR, SRC, TRPV1, XDH |
3.17074 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, DRD1, ESRRB, F2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PRKCD, PTAFR, SRC, XDH |
3.17074 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.1606 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, F2, HMGCR, MIF, PPARA, PRKCD |
3.14892 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP3, MMP9 |
3.14718 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, F2, F3, FABP4, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP3, MMP9, PPARA, PRKCD, PTAFR, SRC, XDH |
3.11283 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTAFR, SRC, TRPV1 |
3.08627 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.08169 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, HCAR2, MIF, MMP12, PTAFR, SRC, TRPV1 |
3.08169 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR |
3.08133 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, TYR |
3.06959 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, PRKCD, SRC |
3.06352 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, HMGCR, MMP2, PPARA, PTAFR, SRC, TRPV1, TYR |
3.04623 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP3, MMP9 |
3.01086 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, PRKCD, PTAFR, SRC, TRPV1 |
2.98223 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP3, MMP9 |
2.96233 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, CYP19A1, DRD1, ESR1, ESR2, F2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PRKCD, SRC, XDH |
2.96039 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, DRD1, ESRRB, F2, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PPARA, PRKCD, SRC, XDH |
2.89398 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP3, MMP9 |
2.8839 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, F2, F3, FABP4, FLT3, HMGCR, IGF1R, MET, MIF, MMP9, PIM1, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
2.8839 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.8828 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP3, MMP9 |
2.87998 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CYP19A1, DRD1, F2, HCAR2, HMGCR, MIF, MMP12, MMP9, PPARA, PRKCD, PTAFR, SRC, TRPV1 |
2.86927 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.86927 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP3, MMP9 |
2.86286 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR, XDH |
2.86048 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, ESR1, F2, FABP3, FABP4, FLT3, MET, SRC, TRPV1 |
2.84964 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.80423 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
2.79187 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.79038 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTAFR, PTGES, SRC |
2.77993 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AR, AURKB, CSNK2A1, CYP2D6, ESR1, ESR2, ESRRA, F2, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP3, MMP9, NR3C1, PPARA, PRKCD, SRC, TRPV1, XDH |
2.75197 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, TYR |
2.674 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC |
2.64882 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.63667 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PIM1, PPARA, PTGES, TYR |
2.60007 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, PRKCD, SRC |
2.60007 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, F2, MMP3, PRKCD, TRPV1, XDH |
2.55954 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, DRD1, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, SRC, XDH |
2.55269 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, PPARA, PRKCD, SRC, TRPV1 |
2.55256 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC |
2.54431 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, DRD1, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, SRC, XDH |
2.54316 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, F2, MMP12, PPARA, PRKCD |
2.54109 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, ESRRB, F2, FLT3, HMGCR, KDR, MIF, MMP9, PRKCD, SRC, XDH |
2.50907 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.49918 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PPARA, PRKCD |
2.49918 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, FABP3, PPARA, TRPV1 |
2.49689 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, HMGCR, IGF1R, KDR, MIF, PRKCD, SRC, XDH |
2.47338 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC |
2.4675 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.46365 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.46234 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46234 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46234 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD, SRC |
2.45394 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, F2, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, PTAFR, SRC |
2.43291 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, MAOA |
2.41876 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.40898 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.38437 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, F2, KDR, MET, MIF, MMP1, MMP12, MMP9, PRKCD, PTAFR, SRC |
2.38413 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA3, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, F2, MIF, MMP2, MMP3, MMP9, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1 |
2.38385 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, DRD1, F2, MIF, MMP9, PRKCD, PTAFR |
2.38315 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTAFR, SRC |
2.37467 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, MAOA |
2.36011 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
2.36011 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, F2, PPARA, PRKCD |
2.34724 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AR, AXL, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, PGR, PTAFR, SRC |
2.33556 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, MET, TRPV1 |
2.29764 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX5, APP, AR, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, F2, FABP3, MIF, MMP12, MMP9, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
2.28404 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.27979 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, PRKCD |
2.27527 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, PRKCD |
2.26998 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, DRD1, F2, FABP4, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PRKCD, SRC, XDH |
2.26363 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
2.26363 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1 |
2.2581 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, HMGCR, KDR, MIF, SRC, XDH |
2.24744 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2325 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, CSNK2A1, DRD1, ESR1, F2, F3, FABP4, FLT3, HMGCR, IGF1R, MIF, MMP9, PRKCD, PTAFR, SRC, XDH |
2.22807 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ESR1, HMGCR, IGF1R, MET, MIF, MMP9, PRKCD, SRC, XDH |
2.22027 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.22027 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.22027 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.22027 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, ESR1, F2, FABP3, MIF, MMP12, MMP9, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
2.20015 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX5, APP, AR, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, F2, FABP3, MIF, MMP12, MMP9, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
2.1979 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.19095 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR |
2.16582 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, PRKCD, SRC |
2.16582 |
[BP] GO:0010942 |
positive regulation of cell death
|
CYP1B1, F3, HCAR2, HMGCR, MMP3, MMP9, PRKCD, SRC, TRPV1, XDH |
2.13733 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, DRD1, ESR1, F2, FABP3, FABP4, MET, TRPV1 |
2.13733 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, F2, FLT3, HMGCR, KDR, MIF, MMP9, PRKCD, SRC, XDH |
2.13065 |
[BP] GO:0045913 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.13065 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.10746 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, F2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP2, MMP9, PRKCD, PTAFR, SRC, TRPV1 |
2.10715 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, F2, HCAR2, HMGCR, MIF, MMP12, PRKCD, SRC |
2.08114 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, CSNK2A1, ESR1, F2, F3, FLT3, HMGCR, KDR, MIF, MMP9, PRKCD, PTAFR, SRC, XDH |
2.07869 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, F2, FABP4, HMGCR, IGF1R, KDR, MIF, MMP12, MMP9, NR3C1, PGR, PPARA, PRKCD, SRC, TRPV1, XDH |
2.06874 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AR, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, SRC, TRPV1, XDH |
2.06182 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, NR3C1, PTAFR, SRC |
2.05835 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, DRD1, ESR1, PGR, SRC |
2.05184 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.05114 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES |
2.04351 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.04295 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.02767 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, DRD1, PRKCD |
2.02767 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, AXL, F2, MIF, PTAFR, PTGES, TRPV1 |
2.01707 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.01707 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, F2, KDR, MIF, MMP1, MMP12, MMP9, PRKCD, SRC |
2.00206 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, F2, HCAR2 |
2.00206 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.46412 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, F2, FLT3, HMGCR, HSD11B1, HSD17B2, NR3C2, PTGES |
3.08169 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, F2, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD17B1, HSD17B2, KDR, MAOA, MIF, MMP2, MMP9, NR3C1, NR3C2, PGR, PIM1, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR, XDH |
3.08169 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, HMGCR, HSD11B1, HSD17B2, NR3C2, PTGES |
2.8059 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, F2, F3, FLT3, HCAR2, HMGCR, HSD11B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP2, NR3C2, PGR, PIM1, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR |
2.14412 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, TYR, XDH |
24.0963 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.2663 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, PTAFR, PTGES, SRC, TRPV1, TYR, XDH |
15.9101 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.847 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PPARA |
12.4292 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.5212 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, TRPV1, TYR, XDH |
10.5931 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F2, F3, FLT3, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP3, MMP9, PIM1, PRKCD, PTGES, SRC, TYR, XDH |
9.66887 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP12, MMP2, MMP3, MMP9, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCD, TRPV1, TYR, XDH |
9.42962 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA |
9.25861 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.52662 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, NR3C2, PGR |
7.83342 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD11B1, HSD17B1, HSD17B2, MAOA, TYR, XDH |
7.5566 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
7.54824 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, PTAFR, TRPV1 |
7.1901 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
7.06898 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
6.9409 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA |
6.74967 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA |
6.74967 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PTAFR, TRPV1 |
6.55838 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
6.25446 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PTAFR, TRPV1 |
5.70018 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HMGCR, HSD17B1, PTGES, SRC, XDH |
5.50043 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.48104 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PTAFR, TRPV1 |
5.48104 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.35428 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD17B1, HSD17B2, XDH |
5.18351 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.13956 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, DRD1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PTAFR, TRPV1 |
5.01827 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
4.78951 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.57087 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, FLT3, IGF1R, KDR, MET, PIM1, PPARA, PRKCD, SRC, TRPV1 |
3.78191 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.43797 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
3.34985 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
3.28948 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F2, F3, MMP1, MMP12, MMP2, MMP3, MMP9 |
3.11144 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.01086 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1 |
2.87626 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.86927 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.86927 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.75449 |
[MF] GO:0004252 |
None
|
F2, F3, MMP1, MMP12, MMP2, MMP3, MMP9 |
2.60007 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, CSNK2A1, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PGR, TRPV1, TYR, XDH |
2.52517 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.45394 |
[MF] GO:0004222 |
metalloendopeptidase activity
|
MMP1, MMP12, MMP2, MMP3, MMP9 |
2.34724 |
[MF] GO:0008236 |
None
|
F2, F3, MMP1, MMP12, MMP2, MMP3, MMP9 |
2.34724 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.22027 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PRKCD, SRC |
2.17216 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.14412 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.0604 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, CYP1A1, CYP1A2, CYP2A6, ESR1, ESR2, ESRRB, F3, HMGCR, MET, MIF, NR3C1, PGR, PPARA, PRKCD, PTAFR, SRC |
2.0604 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CSNK2A1, F2, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MET, PIM1, PRKCD, PTAFR, PTGES, SRC, TRPV1, XDH |
2.04351 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04295 |